Anxiety and depression are common entities in patients diagnosed with Chronic Obstructive Pulmonary Disease (COPD). This study aimed to determine the prevalence of affective comorbidity (depression and anxiety) associated with lung function, functional capacity, dyspnea, and quality of life; as well as the differences between groups of patients diagnosed with COPD associated with biomass (COPD-BE) and patients with COPD secondary to tobacco (COPD-TS). Comparative cross-sectional observational study. Multiple hierarchical regression models, analysis of variance, and covariance were carried out. A total of 291 COPD patients were evaluated, symptoms of depression were found to be higher in patients with COPD-BE than in patients with COPD-TS (5.3 ± 4.2 versus 4.2 ± 4, 1, p = 0.016), as well as anxiety complications (4.1 ± 3.8 versus 3.8 ± 3.3, p = 0.095), although with anxiety it was not statistically significant, being adjusted for age and FEV1. Patients with COPD-BE had higher prevalence of depression, compared to COPD-TS (41.2% versus 27.7%, p = 0.028). In the multivariate regression models, the variables of dyspnea and quality of life were associated with depression and anxiety, explaining 25% and 24% of the variability, respectively. Depression is higher in COPD-BE patients compared to COPD-TE patients, it is necessary to consider affective comorbidity in routine evaluation and provide a comprehensive intervention to prevent the effects on other clinical conditions of the disease.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price includes VAT (USA)
Tax calculation will be finalised during checkout.
Almagro, P., Cabrera FJ., J Diez-Manglano., R Boixeda., J Mercade., ... Soriano, J. B. (2015). Comorbidome and short-term prognosis in hospitalised COPD patients: The ESMI study. European Respiratory Journal, 46(3), 850–853. https://doi.org/10.1183/09031936.00008015
Antonelli-Incalzi, R., Imperiale, C., Bellia, V., Catalano, F., Scichilone, N., Pistelli, R., & Rengo, F. (2003). Do GOLD stages of COPD severity really correspond to differences in health status? European Respiratory Journal, 22(3), 444. https://doi.org/10.1183/09031936.03.00101203
Atlantis, E., Fahey, P., Cochrane, B., & Smith, S. (2013). Bidirectional associations between clinically relevant depression or anxiety and COPD: A systematic review and meta-analysis. Chest, 144(3), 766–777. https://doi.org/10.1378/chest.12-1911
Bestall, J. C., Paul, E. A., Garrod, R., Garnham, R., Jones, P. W., & Wedzicha, J. A. (1999). Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax, 54(7), 581–586. https://doi.org/10.1136/thx.54.7.581
Blakemore, A., Dickens, C., Chew-Graham, C. A., Afzal, C. W., Tomenson, B., Coventry, P. A., & Guthrie, E. (2019). Depression predicts emergency care use in people with chronic obstructive pulmonary disease: A large cohort study in primary care. International Journal of Chronic ObstRuctive Pulmonary Disease, 14, 1343–1353. https://doi.org/10.2147/COPD.S179109
Brennan, C., Worrall-Davies, A., McMillan, D., Gilbody, S., & House, A. (2010). The Hospital Anxiety and Depression Scale: A diagnostic meta-analysis of case-finding ability. Journal of Psychosomatic Research, 69(4), 371–378. https://doi.org/10.1016/j.jpsychores.2010.04.006
Camp, P. G., Ramirez-Venegas, A., Sansores, R. H., Alva, L. F., McDougall, J. E., Sin, D. D., Pare, P. D., Muller, N. L., Silva, C. I. S., Rojas, C. E., & Coxson, H. O. (2014). COPD phenotypes in biomass smoke- versus tobacco smoke-exposed Mexican women. European Respiratory Journal, 43(3), 725–734. https://doi.org/10.1183/09031936.00206112
Chronic respiratory diseases. (n.d.). Retrieved June 1, 2020, from https://www.who.int/westernpacific/health-topics/chronic-respiratory-diseases
Deng, D., Zhou, A., Chen, P., & Shuang, Q. (2020). CODEXS: A new multidimensional index to better predict frequent COPD Exacerbators with inclusion of depression score. International Journal of Chronic Obstructive Pulmonary Disease, 15, 249–259. https://doi.org/10.2147/COPD.S237545
Di Marco, F., Verga, M., Reggente, M., Maria Casanova, F., Santus, P., Blasi, F., Allegra, L., & Centanni, S. (2006). Anxiety and depression in COPD patients: The roles of gender and disease severity. Respiratory Medicine, 100(10), 1767–1774. https://doi.org/10.1016/j.rmed.2006.01.026
Ding, K. Q., Lai, Z. H., Zhang, Y., Yang, G. Y., He, J. R., & Zeng, L. L. (2021). Monocyte-to-lymphocyte ratio is associated with depression 3 months after stroke. Neuropsychiatric Disease and Treatment, 17, 835–845. https://doi.org/10.2147/NDT.S299462
Dua, R., Das, A., Kumar, A., Kumar, S., Mishra, M., & Sharma, K. (2018). Association of comorbid anxiety and depression with chronic obstructive pulmonary disease. Lung, 35(1), 31–36. https://doi.org/10.4103/lungindia.lungindia_537_16
Hanania, N. A., & O’Donnell, D. E. (2019). Activity-related dyspnea in chronic obstructive pulmonary disease: Physical and psychological consequences, unmet needs, and future directions. International Journal of Chronic Obstructive Pulmonary Disease, 14, 1127–1138. https://doi.org/10.2147/COPD.S188141
Jones, P. W., Harding, G., Berry, P., Wiklund, I., Chen, W.-H., & Kline Leidy, N. (2009). Development and first validation of the COPD Assessment Test. European Respiratory Journal, 34(3), 648. https://doi.org/10.1183/09031936.00102509
Khdour, M. R., Hawwa, A. F., Kidney, J. C., Smyth, B. M., & McElnay, J. C. (2012). Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD). European Journal of Clinical Pharmacology, 68(10), 1365–1373. https://doi.org/10.1007/s00228-012-1279-5
Long, J., Ouyang, Y., Duan, H., Xiang, Z., Ma, H., Ju, M., & Sun, D. (2020). Multiple factor analysis of depression and/or anxiety in patients with acute exacerbation chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease, 15, 1449–1464. https://doi.org/10.2147/COPD.S245842
Mathew, A. R., Yount, S. E., Kalhan, R., & Hitsman, B. (2019). Psychological functioning in patients with chronic obstructive pulmonary disease: A preliminary study of relations with smoking status and disease impact. Nicotine & Tobacco Research, 21(5), 686–690. https://doi.org/10.1093/ntr/nty102
Mewes, R., Rief, W., Kenn, K., Ried, J., & Stenzel, N. (2016). Psychological predictors for health-related quality of life and disability in persons with chronic obstructive pulmonary disease (COPD). Psychology & Health, 31(4), 470–486. https://doi.org/10.1080/08870446.2015.1111369
Miravitlles, M., Izquierdo, J. L., Esquinas, C., Pérez, M., Calle, M., López-Campos, ... de Lucas, P. (2017). The variability of respiratory symptoms and associated factors in COPD. Respiratory Medicine, 129, 165–172. https://doi.org/10.1016/j.rmed.2017.06.017
Orozco, M. J. N., Terán, B. P., Casarrubias, V. B., & García, R. R. (2013). Escala de Ansiedad y Depresión Hospitalaria (hads): validación en pacientes mexicanos con infección por vih. Psicología Iberoamericana, 21(2), 29–37.
Pascal, O. I., Trofor, A. C., Lotrean, L. M., Filipeanu, D., & Trofor, L. (2017). Depression, anxiety and panic disorders in chronic obstructive pulmonary disease patients: Correlations with tobacco use, disease severity and quality of life. Tobacco Induced Diseases, 15, 23–23. https://doi.org/10.1186/s12971-017-0128-9
Pathak, U., Gupta, N. C., & Suri, J. C. (2020). Risk of COPD due to indoor air pollution from biomass cooking fuel: A systematic review and meta-analysis. International Journal of Environmental Health Research, 30(1), 75–88. https://doi.org/10.1080/09603123.2019.1575951
Pérez-Padilla, J. R., Regalado-Pineda, J., & Vázquez-García, J. C. (2001). Reproducibilidad de espirometrías en trabajadores mexicanos y valores de referencia internacionales. Salud Pública De México. https://doi.org/10.1590/S0036-36342001000200006
Pérez-Padilla, R., Regalado, J., Vedal, S., Paré, P., Chapela, R., Sansores, R., & Selman, M. (2012). Exposure to biomass smoke and chronic airway disease in Mexican women. A case–control study. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/ajrccm.154.3.8810608
Pooler, A., & Beech, R. (2014). Examining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: A systematic review. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/COPD.S53255
Ramírez-Venegas, A., Sansores, R. H., Pérez-Padilla, R., Regalado, J., Velázquez, A., Sánchez, C., & Mayar, M. E. (2006). Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco. American Journal of Respiratory and Critical Care Medicine, 173(4), 393–397. https://doi.org/10.1164/rccm.200504-568OC
Ramírez-Venegas, A., Velázquez-Uncal, M., Pérez-Hernández, R., Guzmán-Bouilloud, N. E., Falfán-Valencia, R., Mayar-Maya, M. E., Aranda-Chávez, A., & Sansores, R. H. (2018). Prevalence of COPD and respiratory symptoms associated with biomass smoke exposure in a suburban area. International Journal of Chronic Obstructive Pulmonary Disease, 13, 1727–1734. https://doi.org/10.2147/COPD.S156409
Regalado, J., Pérez-Padilla, R., Sansores, R., Páramo Ramirez, J. I., Brauer, M., Paré, P., & Vedal, S. (2006). The effect of biomass burning on respiratory symptoms and lung function in rural Mexican women. American Journal of Respiratory and Critical Care Medicine, 174(8), 901–905. https://doi.org/10.1164/rccm.200503-479OC
Gold Reports for Personal Use. (n.d.). Global Initiative for Chronic Obstructive Lung Disease - GOLD. Retrieved June 2, 2020, from https://goldcopd.org/gold-reports/
Sampaio, M. S., Vieira, W. A., Bernardino, Í. M., Herval, Á. M., Flores-Mir, C., & Paranhos, L. R. (2019). Chronic obstructive pulmonary disease as a risk factor for suicide: A systematic review and meta-analysis. Respiratory Medicine, 151, 11–18. https://doi.org/10.1016/j.rmed.2019.03.018
Snaith, R. P. (2003). The hospital anxiety and depression scale. Health and Quality of Life Outcomes, 1, 29–29. https://doi.org/10.1186/1477-7525-1-29
Yohannes, A. M., Kaplan, A., & Hanania, N. A. (2018). Anxiety and depression in chronic obstructive pulmonary disease: Recognition and management. Cleveland Clinic Journal of Medicine, 85(2 suppl 1), S11. https://doi.org/10.3949/ccjm.85.s1.03
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
We thank to the Council of Science and Technology Mexico (CONACYT) for a doctoral grant that AH-P received [Granter Number: 286181], and the participating health professionals and patients with COPD who made this study possible by their enthusiastic participation.
Conflict of interest
The authors declare that they have no competing interests.
Research Involving Human and Animal Rights
All Procedures performed in studies involving human participants were in accordance with the ethical standards of National Institute of Respiratory Diseases Ismael Cosío Villegas Mexico and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by the authors.
Informed consent was obtained from all individual participants included in the study.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Hernández-Pérez, A., Vargas-Núñez, I., Moreno-Jiménez, B. et al. Affective Comorbidity Associated with Symptoms, Lung Function, and Differences Between Patients with COPD for Biomass and Tobacco Smoke Exposure. J Clin Psychol Med Settings (2021). https://doi.org/10.1007/s10880-021-09828-7
- Chronic obstructive pulmonary disease